Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 April 2024 | Story Lunga Luthuli | Photo SUPPLIED
Dr Kamwendo
Dr Juliet Kamwendo champions gender-inclusive climate action in Africa. Her expertise at the recently held AFR100 workshop highlighted vital steps towards sustainable and equitable development.

Dr Juliet Kamwendo, Lecturer and Programme Director for Gender Studies in the Centre for Gender and Africa Studies at the University of the Free State, is spearheading efforts to integrate gender considerations into Africa's climate restoration agenda. Reflecting on her involvement, Dr Kamwendo stated, "This is particularly crucial, as women make up almost 50% of the population in Africa, and the depletion and degradation of land affect them disproportionately."

She recently served as a gender expert at the AUDA-NEPAD AFR100 workshop in Ouagadougou, Burkina Faso, from 25 to 29 March 2024. This initiative aims to restore forests and degraded land across Africa by 2030, with a focus on gender equality.

The workshop emphasised the integration of gender perspectives into the AFR100 project, acknowledging the disproportionate impact of land degradation on women. Dr Kamwendo's expertise highlighted the need to empower women in climate change interventions, addressing existing gender inequalities exacerbated by environmental degradation.

“Women – who are primarily responsible for household food security and water provision – bear the brunt of environmental degradation, leading to increased workloads, reduced income opportunities, and heightened vulnerability to climate-related disasters. Furthermore, the loss of forest cover and biodiversity further exacerbates the challenges faced by women, particularly in rural areas where they depend heavily on natural resources for their livelihoods,” added Dr Kamwendo.

Her participation highlights academia's crucial role in fostering inclusive and sustainable development, emphasising interdisciplinary collaboration to tackle complex environmental challenges. Through initiatives such as AFR100, stakeholders are working towards a more resilient and gender-responsive future for Africa.

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept